Exenatide is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication,
belonging to the group of incretin mimetics, approved in April 2005 for the
Jul 15, 2015 ... Exenatide injection may increase the risk that you will develop tumors of the
thyroid gland, including medullary thyroid carcinoma (MTC; a type ...
BYETTA (exenatide) is a synthetic peptide that was originally identified in the
lizard Heloderma suspectum. Exenatide differs in chemical structure and ...
Learn about clinical pharmacology for the drug Byetta (Exenatide Injection).
Exenatide is an antidiabetic injection that is used in treating type 2 diabetes.
Read more about diabetes treatments and antidiabetic injections at Patient.
May 2, 2016 ... Easy to read patient leaflet for exenatide. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Learn about BYDUREON® (exenatide extended-release for injectable
suspension), a non-insulin treatment option for adults with type 2 diabetes
available in the ...
Byetta (exenatide) is approved as an adjunct to diet and exercise to improve
glycemic control in adults with type 2 diabetes mellitus. Adverse reactions or
Drug Name · Active Ingredients · BYDUREON, EXENATIDE SYNTHETIC.
BYDUREON PEN, EXENATIDE SYNTHETIC. BYETTA, EXENATIDE SYNTHETIC
May 4, 2005 ... Dr. Buse: Exenatide is an incretin mimetic. It has structural similarity and binds to
the receptor for GLP-1 and displays a similar broad range of ...